-
-
-
-
-
-
-
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
-
-
-
-
-
-
-
Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions
-
-
-
-
-
-
-
Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach
-
-
-
-
-
-
-
Emergent BioSolutions Reports Financial Results for Second Quarter 2022
-
-
-
-
-
-
-
Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021
-
-
-
-
-
-
-
Emergent BioSolutions Reports Financial Results For Third Quarter 2021
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Churchill, Emergent BioSolutions, and Verus International and Encourages Investors to Contact
-
924,308 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All